Form 8-K - Current report:
SEC Accession No. 0000950170-24-102921
Filing Date
2024-09-03
Accepted
2024-09-03 17:13:15
Documents
12
Period of Report
2024-08-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlis-20240829.htm   iXBRL 8-K 50208
2 EX-10.1 tlis-ex10_1.htm EX-10.1 38795
  Complete submission text file 0000950170-24-102921.txt   243129

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tlis-20240829.xsd EX-101.SCH 47767
14 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20240829_htm.xml XML 4895
Mailing Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607
Business Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40047 | Film No.: 241274998
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)